New Jersey S 1327: Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-02-03)

State: New Jersey · Session: 220 · Bill: S 1327

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Beach, James

View New Jersey S 1327 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.